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Abstract: The specificity and affinity of antibody-antigen interactions is a fundamental way 
to achieve reliable biosensing responses. Different proteins involved with dry eye dysfunction: 
ANXA1, ANXA11, CST4, PRDX5, PLAA and S100A6; were validated as biomarkers. In this 
work several antibodies were tested for ANXA1, ANXA11 and PRDX5 to select the best 
candidates for each biomarker. The results were obtained by using Biophotonic Sensing Cells 
(BICELLs) as an efficient methodology for label-free biosensing and compared with the 
Enzyme-Linked Immuno Sorbent Assay (ELISA) technique. 
  
OPEN ACCESS
Sensors 2015, 15 19820 
 
 
Keywords: photonic sensing cells BICELLs; biosensors; label-free immunoassay;  
dry eye biomarkers 
 
1. Introduction 
As reported by Lemp et al. [1], dry eye disease is a multifactorial chronic disorder of the ocular 
surface that affects up to 100 million people worldwide. Diagnosis and management of dry eye has been 
a source of frustration to clinicians for a lack of correlation between signs and symptoms. Dry eye (DE) 
and meibomian gland dysfunction (MGD) are common inflammatory ocular surface diseases affecting 
tear film stability and ocular surface integrity. The pathophysiology of both conditions is complex and 
thought to represent the interaction of multiple mechanisms including tear film hyperosmolarity, 
instability, and subsequent activation of an inflammatory cascade, with release of inflammatory 
mediators into the tears, which in turn can damage the ocular surface epithelium. 
Label-free optical biosensors have been demonstrated to be a good technology for In-Vitro Diagnostics 
(IVD) due to advantages versus labeled techniques [2,3]. The short turnaround and cost-effectiveness 
advantages are very important factors for final users and health professionals as a whole. Mainly, three 
important factors are connected with the Limit of Detection (LoD) of optical label-free biosensing: the 
transducer sensitivity, resolution of the optical reader and the performance of the immunoassay. The latter 
one, the antigen-antibody interaction, plays an important role to achieve a competitive LoD. In this sense, 
the study of specificity and affinity of antibody-antigen interactions is fundamental for understanding the 
biological activity of these proteins, as well as to develop suitable biosensors. 
As it is well explained [4,5], a highly specific bimolecular association is achieved by the interaction between 
an antibody with its corresponding antigen, which involves various non-covalent interactions between the 
antigen epitope and the variable region of the antibody molecule. These interactions (ionic bonds, hydrogen 
bonds, hydrophobic interactions and van der Walls interactions) are needed for a strong antigen-antibody 
binding requiring a high degree of complementarity between antigen (Ag) and antibody (Ab). 
Affinity is the strength of binding of a single molecule to its corresponding ligand. Typically it is 
determined by the equilibrium dissociation constant (KD), which is used to evaluate biomolecular 
interactions. The measurement of the reaction rate constants can be used to define an equilibrium or 
affinity constant (1/KD).Thus, the smaller the KD value, the greater the affinity of an antibody with its 
target. Antibodies with high affinity have an association constant Ka > 107 M−1 [6,7]. 
Biomarkers are frequently used in clinical trials of therapeutics for the assessment of disease states 
and also for evaluating diagnostic devices. In previous works, several biomarkers where validated for 
dry eye disease: S100A6, CST4, MMP9, PRDX5, ANXA1, ANXA11, PLAA [8]. 
In previous articles, our research group has also proven an efficient methodology for label-free biosensing 
by using Biophotonic Sensing Cells (BICELLs) [9,10], and particularly for dry eye diseases [11]. According 
to this, in this article we study the affinity of several antibodies for biomarkers: ANXA1, ANXA11, 
PRDX5 and S100A6 using BICELLs based on SU8 resist Fabry-Perot interferometers with an optical 
read-out of the biosensor based on the interferometry.  
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The label-free optical technique based on BICELLs is a well-reported optical technique where 
basically changes in the refractive index are produced by the recognition or accumulation events of 
biomolecules onto the sensing surface [9]. This BICELLs method is a label-free, which means that it is 
not necessary label-molecules for the detection. However, in the classical Enzyme-Linked Immuno 
Sorbent Assay (ELISA) protocols a labeled-molecule for subsequent detection is needed. 
2. Experimental Section 
2.1. Production of Mouse mAbs 
The mAbs were obtained from female Balb/c mice immunized by intraperitoneal injections with the 
recombinant proteins ANXA1, ANXA11 and PRDX5, separately. The fusion was performed using a Clona 
Cell-HY kit following the manufacturer’s instructions (Stemcell Technologies, Vancouvert, BC, Canada). 
Briefly, micesplenocytes were fused with immortal NSO-1 cells (kindly donated by Margaret Goodall, 
University of Birmingham, Birmingham, UK) with the addition of polyethylene glycol (Clona Cell-HY 
kit). The resulting mix was grown in selective agar (ClonaCell-HY kit) on 96-well plates.  
Screening of positive hybridoma cell culture supernatant was tested by indirect ELISA. Desired clones 
were expanded, cultured on a large scale and cryopreserved. The three best hybridomas of each fusion were 
selected (Table 1) based on its productivity, ELISA signal and growth rate for further studies. 
mAbisotypes were determined with the mouse mAbisotyping kit (Sigma-Aldrich, Madrid, Spain), 
and were purified by Protein G (GE Healthcare, Buckinghamshire, UK) affinity column 
chromatography. Their purity was confirmed by SDS/PAGE. All mAbs were produced and purified by 
AntibodyBcn (Barcelona, Spain). 
Table 1. Antibodies selected from each fusion. 
Protein Antibody Selected 
ANXA 1 
P4D1 
P6D7 
P10B12 
ANXA11 
P1B11 
P3F9 
P4D9 
PRDX5 
P3G1 
P5H6 
P9F4 
2.2. Affinity ELISA Assay 
In order to establish which mAb shown a greater affinity to its own antigen, calibrating curves were 
carried out by indirect ELISA assays as follows. Ninety-six-well ELISA plates (Santa Cruz Biotech, 
Dallas, TX, USA) were coated for 4 h at 37 °C with 100 µL per well of each protein in serial dilutions (1:2) 
from 200 ng/mL to 3.125 ng/mL in 0.2 M carbonate buffer (pH 9.6). Washing was done using 0.05% 
Phosphate Buffer Saline (PBS)-Tween 20 (PBS-T). Wells were blocked with 2.5% non-fat milk-PBST 
overnight at 4 °C. Afterwards plates are incubated with 100 µL purified mAbs at 5 μg/mL for 1 h at 37 °C. 
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Ab binding was detected with HRP-conjugated anti-mouse IgG (HRP stands for Horseradish Peroxidase; 
1:500 in PBS-T; Santa Cruz Biotech), followed by color development with tetramethylbenzidine ELISA 
substrate (TMB; Thermo Fisher Scientific, Uppsala, Sweden). The reaction was stopped with 1 M HCl and 
read at 450 nm by a Multiscan FC microplate reader (Thermo Fisher Scientific). 
2.3. Biosensor 
For this experimental work we used, as photonic transducer, a Biophotonic Sensing Cell (BICELL) 
based on Fabry-Perot interferometers of SU8 polymeric resist that exhibits a sensitive optical label-free 
biosensing capability. The Fabry-Perot interferometer is the biotransducer of the biosensor itself. Bicells 
are based on different type of interferometers and are normally square sensing areas where the 
recognition events take place. For this particular case, the interferometer employed is a single SU8 layer 
Fabry-Perot interferometer where part of the light is transmitted through the SU8 reaching the substrate. 
As a result the interference is produced by the mixed beams coming from the SU8 (and its biomolecules) 
and the substrate. The large number of interfering beams produces an interferometry profile with a high 
resolution suitable for biosensing. 
We employed SU8 2000.5 (Microchem Corp., Newton, MA, USA) diluted in cyclopentanone [12] for 
the fabrication of BICELLs. The SU8 resist was deposited by spinning at 3000 rpm for 3 min, then the film 
was soft-baked at 70 °C for 1 min. An exposure to UV light process was then carried out, followed by a  
post-bake step at 70 °C for 5 min in order to give a stable thin film. The SU8 surface of the BICELLs was 
treated with sulfuric acid (95% for 10 s) in order to have a hydrophilic sensing surface. As a result of this 
treatment, the SU8 epoxy groups are opened and suitable to immobilize covalently the protein [13]. 
By monitoring the changes in the interferometric profile of theoptical mode response, the 
immobilization of protein and the recognition of several antibodiescan be properly monitored. Therefore, 
it is possible to detect the response of the antibody for each biomarker. 
2.4. Optical Characterization of the Biosensor and Sensing Principle 
The optical readout of the biosensor was accomplished by a Fourier transform visible-infrared 
(FT-VIS-IR) spectrometer (Vertex 70 adapted to the visible range, Bruker, Madrid, Spain) after 
each incubation/washing step. We followed the well-described procedure very recently reported 
in the literature [9] (see in Figure 1a–c). 
 
Figure 1. (a) Optical setup for measurements and biochemical diagram of the immunoassay; 
(b) optical response for the BICELLs; (c) Bicells used in the immunoassay. 
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2.5. Immunoassay Procedure 
The indirect immunoassay Protein (ANXA1, ANXA11 and PRDX5)/antibody was carried out by a 
covalent binding of the protein onto the BICELLs SU8 sensing surface until saturation for testing the 
best clone obtained for AntibodyBcn (Barcelona, Spain). The covalent bond occurs between epoxy ring 
of SU8 and amine groups of proposed proteins. The incubation of proteins was made until saturation 
with a volume of 60 µL, with a concentration of 50 µg·mL−1 in phosphate buffered saline (pH 7.4,), and 
at temperature of 37 °C during 20 min. Then, the surfaces were rinsed with deionize water (DI-H2O) and 
blown with dry and clean dust-less air under clean environment. 
Avoid nonspecific adsorption is a very important step. In fact, the blocking step avoids the unspecific 
bounding, especially important for direct immunoassay, where the antibody is firstly immobilized onto the 
sensing surface. However, for this article, we did not consider using a blocking step because we 
immobilized the biomarker(indirect immunoassay) until saturation, supposing that the sensing surface is 
completely filled with the protein (there are a biofilm of protein according with our previous simulations). 
Then, we proceeded to recognize the corresponding antibody. The recognition curve of antibody with 
concentrations 0.2, 0.5, 1.5, 2.5, 5, 10, 25, 5, 10, 25, 50 and 100 µg·mL−1 in PBS-pH 7.4 was observed at 
37 °C for 20 min for each incubation step. Thus, for each antibody concentration the corresponding 
BICELLs were washed with PBS-T and water and blown with dry and clean dust-less air. 
3. Results and Discussion 
3.1. Results Obtained by ELISA Technique: Affinity Analysis by ELISA 
Selected monoclonal antibodies were individually characterized to determine which of them showed 
the highest affinities which meant strong binding ability to their antigen and would lead to its strong 
applied value in areas such as detection and diagnosis. Thus, for ANXA 1 (Figure 2a), the antibody 
P10B12 did not show a significant signal even at high ligand concentrations. The other two antibodies 
shown a slightly improvement, being antibody P6D7 a little better than the antibody P4D1, with 
dissociation constants KD of 2.40 μM, and 27.01 μM, respectively. Both antibodies give signals too far 
from the saturation range, however both antibodies could be used for ANXA1 detection. 
In the case of monoclonal antibodies against protein ANXA11 (Figure 2b) all of them showed 
apparently good signals; both P3F9 and P1B11 are close to the saturating point at the highest ligand 
concentration employed in the assay. Although P3F9 demonstrated the best ability to bind to antigen 
ANXA11, P1B11 and P4D9 could be also used for an effective detection of the protein. The dissociation 
constant (KD) of P3F9, P4D9 and P1B11 were 19 nM, 4.87 µM and 1.56 µM, respectively. 
Finally in the case of antibodies the intensity shown by the three selected antibodies against  
PRDX5 (Figure 2c) reveals a high affinity of all of them. Antibody P9F4 has the higher affinity to 
PRDX5 with a KD of 17.66 nM. Both P3G1 and P5H6 antibodies have a similar affinity rate with a KD 
of 22.05 nM and 27.01 nM, respectively. 
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(a) ANXA1 
 
(b) ANXA11 
 
(c) PRDX5 
Figure 2. Calibration curves for selected monoclonal antibodies. The absorbance 
measurements are plotted against the protein concentration ranging from 3.125 ng·mL−1 to 
200 ng·mL−1: (a) ANXA1; (b) ANXA11; (c) PRDX5. 
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3.2. Results Obtained by Optical Label-Free Technique 
In order to analyze the response of the antibody for each biomarker, we evaluated the spectral 
response for different concentrations of antibody. Figure 3 shows the measured interference dip 
wavenumber displacement of Fabry-Perot interferometer for increasing concentrations of the different 
antibodies. In the analyte-receptor recognition reaction, the dissociation constant is expressed as  
KD = [A]·[R]/[AR], where [A] is the free analyte concentration, [R] is the free receptor concentration 
and [AR] is the analyte-receptor complex concentration. At the equilibrium, KD = kd/ka, kd and ka are 
the kinetic constants for the dissociation and association process, respectively. Thus, KD can be 
considered as the reciprocal of the analyte affinity towards the receptor. In our experiment the receptor 
concentration is assumed to be [R] = [R]total − [AR] and when 50% of the binding sites are occupied 
([AR] = 0.5·[R]total), the dissociation constant is the free analyte concentration KD = [A]. Therefore, the 
KD value is the antibody concentration causing a response in the transduction equal to 50% of the total 
transduction change after saturation. In Figure 3a (for ANXA1) two clones were studied (P4D1 and 
P6D7). The signal for P4D1 clone is much lower than P6D7 clone. Both clones gave an affinity constant 
values very low (P6D7-KD = 1.6 × 10−4 M and P4D1 = 8.86 × 10−5 M), resulting in a poor affinity for 
the protein ANXA1 because antibodies with high affinity must have KD < 10−7 M. For these reasons, 
both antibodies are not considered very good for recognizing the ANXA1 biomarker. 
For Anxa11 (Figure 3b) he three antibodies offered a good dynamic range with dissociation constant 
values lower than 10−7 M. The values obtained for P3F9, P4D9 and P1B11 are 20 nM, 15 nM and  
33.3 nM, respectively. Figure 3b shows that all antibodies reach the point of saturation below 10 µg·mL−1 
and the dissociation constants values obtained show the high affinity of the antibodies to its 
corresponding antigen. 
Finally for PRDX5 (Figure 3c), three selected antibodies were studied, showing a high affinity towards 
PRDX5. The dissociation constants values obtained for P9F4, P5H6 and P3G1 are 7.3 nM, 23.3 nM and  
26.6 nM, respectively. These values are in agreement with values obtained by the ELISA technique. 
 
(a) ANXA1 
Figure 3. Cont. 
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(b) ANXA11 
 
(c) PRDX5 
Figure 3. Dip shift against antibody concentration for (a) ANXA1; (b) ANXA11; (c) PRDX5. 
3.3. Comparison of the ELISA Technique versus the Optical Label-Free Technique 
Dissociation constant values for eight antibody-antigen systems were compared with ELISA and the 
Optical Label-Free technique. This analysis, shown in Figure 4, indicated that five antibodies have KD 
values in the same order of magnitude with both techniques. However, three antibodies show 
dissociation constant values that differ by two orders of magnitude.  
The differences between both techniques can be justified as follows: the Enzyme-Linked Immuno 
Sorbent Assay (ELISA) technique is a method where affinity constants is determined in dilution and, 
therefore, a real immunoreaction constant is determined. However, by employing the optical 
interferometric technique based on BICELLs, the reaction constant is calculated in the solid-phase, 
leading an apparent constant in a heterogeneous biosensing assay. Moreover, the optimization of 
immunoassay (e.g., pH of buffers, incubation times, and temperature, among others) may have 
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significant implications and influence the antigen-antibody interaction. For this reason, the quantitative 
estimation of the affinity constant with our optical interferometric technique is an essential piece of 
information when setting up a heterogeneous biosensing assay. 
 
Figure 4. Equilibrium dissociation constant (KD) measurements obtained using the Elisa 
technique and the Optical Label-free technique. 
4. Conclusions 
The affinity antigen-antibody for several biomarkers associated with dry eye disease was studied 
using an optical label-free interferometric technique. For this study biophotonic sensing cells (BICELLs) 
based on SU8 photoresist have been used. 
Antibodies for three biomarkers: ANXA1, ANXA11 and PRDX5 were produced. The affinity of the 
antibodies was tested by the ELISA technique calculating their dissociation constant (KD) and therefore 
the affinity to their corresponding antigens. 
An indirect immunoassay until antigen saturation on the sensing surface took place by an optical 
label-free technique was performed. Then, a recognition curve for each antibody was plotted. From this 
curve, an apparent dissociation constant (KD) was calculated and compared with the ELISA result. 
In general terms, antibodies with KD < 10−7 M have high affinity. Therefore, for the ANXA1 
biomarker, two antibodies were studied by using ELISA and the optical label-free technique. As a result, 
both antibodies exhibited poor affinity. However, for the ANXA11 biomarker we observed a good 
affinity reaction: the best antibody is P3F9 for both techniques. Finally, for the PRDX5 biomarker the 
three antibodies also had a good affinity by both techniques. 
As a main conclusion, the comparative analysis of KD indicates a reasonable correlation between both 
techniques in some antigen-antibody pairs. However, in other pairs there are significant differences. We 
consider that the main different values of KD between both IVD techniques are more related with the 
different immunoassays protocols when using ELISA in solution in comparison with the BICELLs based 
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optical interferometric technique in heterogeneous medium. As explained above, parameters such as 
buffer, sample volume, incubation time, blocking steps and washing can impact the determination of the 
KD. Finally, even with the different KD values observed, the proposed interferometric optical label-free 
technique seems to be suitable to study antigen-antibody affinity. 
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